Chapter 11 Glucocorticoid-Regulated Crosstalk Between Arachidonic Acid and Endocannabinoid Biochemical Pathways Coordinates Cognitive-, Neuroimmune-, and Energy Homeostasis-Related Adaptations to Stress

Vitamins and Hormones

Volumn 81, Issue C, 2009, Pages 263-313

  Malcher Lopes, Renato ^a,b   Buzzi, Marcelo ^c  

^a EMBRAPA RECURSOS GENÉTICOS E BIOTECNOLOGIA   (Brazil)

^b UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^c SARAH NETWORK OF REHABILITATION HOSPITALS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; ENDOCANNABINOID; GLUCOCORTICOID; NEUROPROTECTIVE AGENT; PHOSPHOLIPASE A2;

ADAPTATION; ANIMAL; BIOSYNTHESIS; COGNITION; DRUG ANTAGONISM; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; LEARNING; METABOLISM; NERVE CELL PLASTICITY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ARACHIDONIC ACID; COGNITION; CYCLOOXYGENASE 2; ENDOCANNABINOIDS; ENERGY METABOLISM; GLUCOCORTICOIDS; HOMEOSTASIS; HUMANS; LEARNING; NEUROIMMUNOMODULATION; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; PHOSPHOLIPASES A2; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 67651166649     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(09)81011-X     Document Type: Review

References (330)

1. Adesuyi S.A., Cockrell C.S., Gamache D.A., and Ellis E.F. Lipoxygenase metabolism of arachidonic acid in brain. J. Neurochem. 45 (1985) 770-776
2. Ahima R.S. Leptin and the neuroendocrinology of fasting. Front. Horm. Res. 26 (2000) 42-56
3. Ahima R.S., and Osei S.Y. Leptin signaling. Physiol. Behav. 81 (2004) 223-241
4. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., and Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature 382 (1996) 250-252
5. Albrecht D. Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO. Learn. Mem. 14 (2007) 177-184
6. Alkayed N.J., Narayanan J., Gebremedhin D., Medhora M., Roman R.J., and Harder D.R. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke 27 (1996) 971-979
7. Ambrogi Lorenzini C.G., Baldi E., Bucherelli C., Sacchetti B., and Tassoni G. Neural topography and chronology of memory consolidation: A review of functional inactivation findings. Neurobiol. Learn. Mem. 71 (1999) 1-18
8. Andreasson K.I., Savonenko A., Vidensky S., Goellner J.J., Zhang Y., Shaffer A., Kaufmann W.E., Worley P.F., Isakson P., and Markowska A.L. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J. Neurosci. 21 (2001) 8198-8209
9. Arai J., Okada S., Yamaguchi-Shima N., Shimizu T., Sasaki T., Yorimitsu M., Wakiguchi H., and Yokotani K. Role of brain prostanoids in glucagon-like peptide-1-induced central activation of sympatho-adrenomedullary outflow in rats. Clin. Exp. Pharmacol. Physiol. 35 (2008) 965-970
10. Arora S., and Anubhuti. Role of neuropeptides in appetite regulation and obesity-A review. Neuropeptides 40 (2006) 375-401
11. Auclair N., Otani S., Soubrie P., and Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol 83 (2000) 3287-3293
12. Avitsur R., Pollak Y., and Yirmiya R. Administration of interleukin-1 into the hypothalamic paraventricular nucleus induces febrile and behavioral effects. Neuroimmunomodulation 4 (1997) 258-265
13. Bailey J.M. New mechanisms for effects of anti-inflammatory glucocorticoids. Biofactors 3 (1991) 97-102
14. Bamberger C.M., Else T., Bamberger A.M., Beil F.U., and Schulte H.M. Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes. J. Clin. Endocrinol. Metab. 84 (1999) 4055-4061
15. Banks W.A., Kastin A.J., and Durham D.A. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res. Bull. 23 (1989) 433-437
16. Barnes P.J. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332 (1995) 868-875
17. Basselin M., Villacreses N.E., Lee H.J., Bell J.M., and Rapoport S.I. Flurbiprofen, a cyclooxygenase inhibitor, reduces the brain arachidonic acid signal in response to the cholinergic muscarinic agonist, arecoline, in awake rats. Neurochem. Res. 32 (2007) 1857-1867
18. Bauer M.K., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P.J., Bauer J., and Fiebich B.L. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 243 (1997) 726-731
19. Bazan N.G. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32 (2005) 89-103
20. Becker J.L., Grasso R.J., and Davis J.S. Dexamethasone action inhibits the release of arachidonic acid from phosphatidylcholine during the suppression of yeast phagocytosis in macrophage cultures. Biochem. Biophys. Res. Commun. 153 (1988) 583-590
21. Beltramo M., and Piomelli D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11 (2000) 1231-1235
22. Bendinelli P., Piccoletti R., and Maroni P. Leptin rapidly activates PPARs in C2C12 muscle cells. Biochem. Biophys. Res. Commun. 332 (2005) 719-725
23. Berkenbosch F., van Oers J., del Rey A., Tilders F., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 (1987) 524-526
24. Bertolini A., Ferrari A., Ottani A., Guerzoni S., Tacchi R., and Leone S. Paracetamol: New vistas of an old drug. CNS Drug Rev. 12 (2006) 250-275
25. Besedovsky H., del Rey A., Sorkin E., and Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233 (1986) 652-654
26. Bhattacharjee A.K., Chang L., Lee H.J., Bazinet R.P., Seemann R., and Rapoport S.I. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Psychopharmacology (Berl.) 180 (2005) 735-742
27. Bisogno T., Delton-Vandenbroucke I., Milone A., Lagarde M., and Di Marzo V. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch. Biochem. Biophys. 370 (1999) 300-307
28. Bisogno T., Melck D., De Petrocellis L., and Di Marzo V. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J. Neurochem. 72 (1999) 2113-2119
29. Bisogno T., MacCarrone M., De Petrocellis L., Jarrahian A., Finazzi-Agro A., Hillard C., and Di Marzo V. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem. 268 (2001) 1982-1989
30. Bisogno T., De Petrocellis L., and Di Marzo V. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. Curr. Pharm. Des. 8 (2002) 533-547
31. Bisogno T., et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163 (2003) 463-468
32. Bitencourt R.M., Pamplona F.A., and Takahashi R.N. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur. Neuropsychopharmacol 18 (2008) 849-859
33. Blankman J.L., Simon G.M., and Cravatt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14 (2007) 1347-1356
34. Blevins J.E., Schwartz M.W., and Baskin D.G. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R87-96
35. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., and Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202 (1995) 17-20
36. Bondi C.O., Rodriguez G., Gould G.G., Frazer A., and Morilak D.A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 33 (2008) 320-331
37. Bornheim L.M., Kim K.Y., Chen B., and Correia M.A. Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. Biochem. Pharmacol. 50 (1995) 677-686
38. Bosetti F. Arachidonic acid metabolism in brain physiology and pathology: Lessons from genetically altered mouse models. J. Neurochem. 102 (2007) 577-586
39. 2+-dependent phospholipase A2. J. Neurochem. 91 (2004) 1389-1397
40. Boudaba C., Szabo K., and Tasker J.G. Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J. Neurosci. 16 (1996) 7151-7160
41. Boyle P.J., Shah S.D., and Cryer P.E. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting. Am. J. Physiol. 256 (1989) E651-E661
42. Brock T.G., McNish R.W., and Peters-Golden M. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J. Biol. Chem. 274 (1999) 11660-11666
43. Brunetti L., Orlando G., Michelotto B., Ragazzoni E., and Vacca M. Leptin stimulates prostaglandin E2 and F2alpha, but not nitric oxide production in neonatal rat hypothalamus. Eur. J. Pharmacol. 369 (1999) 299-304
44. Cadas H., Gaillet S., Beltramo M., Venance L., and Piomelli D. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci. 16 (1996) 3934-3942
45. Cajal Y., and Jain M.K. Synergism between mellitin and phospholipase A2 from bee venom: Apparent activation by intervesicle exchange of phospholipids. Biochemistry 36 (1997) 3882-3893
46. Calder P.C. Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 33 (2005) 423-427
47. Callahan T.A., and Piekut D.T. Differential Fos expression induced by IL-1beta and IL-6 in rat hypothalamus and pituitary gland. J. Neuroimmunol. 73 (1997) 207-211
48. Camps M., Hou C., Sidiropoulos D., Stock J.B., Jakobs K.H., and Gierschik P. Stimulation of phospholipase C by guanine-nucleotide-binding protein beta gamma subunits. Eur. J. Biochem. 206 (1992) 821-831
49. Cannon W.B. The Wisdom of the Body (1939), WW Norton & Company, New York
50. Carlson G., Wang Y., and Alger B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 5 (2002) 723-724
51. Carrier E.J., Kearn C.S., Barkmeier A.J., Breese N.M., Yang W., Nithipatikom K., Pfister S.L., Campbell W.B., and Hillard C.J. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol. Pharmacol. 65 (2004) 999-1007
52. Carrier E.J., Patel S., and Hillard C.J. Endocannabinoids in neuroimmunology and stress. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 657-665
53. Chalimoniuk M., Glowacka J., Zabielna A., Eckert A., and Strosznajder J.B. Nitric oxide alters arachidonic acid turnover in brain cortex synaptoneurosomes. Neurochem. Int. 48 (2006) 1-8
54. Chang W.C., Kao H.C., and Liu Y.W. Down-regulation of epidermal growth factor-induced 12-lipoxygenase expression by glucocorticoids in human epidermoid carcinoma A431 cells. Biochem. Pharmacol. 50 (1995) 947-952
55. Chen P., Hu S., Yao J., Moore S.A., Spector A.A., and Fang X. Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. Microvasc. Res. 69 (2005) 28-35
56. Chevaleyre V., and Castillo P.E. Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 43 (2004) 871-881
57. Chivers J.E., Cambridge L.M., Catley M.C., Mak J.C., Donnelly L.E., Barnes P.J., and Newton R. Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E release. Eur. J. Biochem. 271 (2004) 4042-4052
58. Chrousos G.P. Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity-A dynamic digital-to-analog modulation. Endocrinology 139 (1998) 437-440
59. Cifone M.G., Migliorati G., Parroni R., Marchetti C., Millimaggi D., Santoni A., and Riccardi C. Dexamethasone-induced thymocyte apoptosis: Apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93 (1999) 2282-2296
60. Clark M.A., Conway T.M., Shorr R.G., and Crooke S.T. Identification and isolation of a mammalian protein which is antigenically and functionally related to the phospholipase A2 stimulatory peptide melittin. J. Biol. Chem. 262 (1987) 4402-4406
61. Coceani F., Lees J., and Dinarello C.A. Occurrence of interleukin-1 in cerebrospinal fluid of the conscious cat. Brain Res. 446 (1988) 245-250
62. Correa F., Mestre L., Molina-Holgado E., Arevalo-Martin A., Docagne F., Romero E., Molina-Holgado F., Borrell J., and Guaza C. The role of cannabinoid system on immune modulation: Therapeutic implications on CNS inflammation. Mini. Rev. Med. Chem. 5 (2005) 671-675
63. Cota D. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol 20 Suppl. 1 (2008) 35-38
64. Craib S.J., Ellington H.C., Pertwee R.G., and Ross R.A. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br. J. Pharmacol. 134 (2001) 30-37
65. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., and Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 98 (2001) 9371-9376
66. Croxtall J.D., Choudhury Q., Tokumoto H., and Flower R.J. Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids (changed from glucorticoids) inhibit G protein-dependent activation of cPLA2 activity. Biochem. Pharmacol. 50 (1995) 465-474
67. Croxtall J.D., Choudhury Q., Newman S., and Flower R.J. Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation. Biochem. Pharmacol. 52 (1996) 351-356
68. Croxtall J.D., Choudhury Q., and Flower R.J. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br. J. Pharmacol. 130 (2000) 289-298
69. Croxtall J.D., van Hal P.T., Choudhury Q., Gilroy D.W., and Flower R.J. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br. J. Pharmacol. 135 (2002) 511-519
70. Dallman M.F., and Jones M.T. Corticosteroid feedback control of ACTH secretion: Effect of stress-induced corticosterone ssecretion on subsequent stress responses in the rat. Endocrinology 92 (1973) 1367-1375
71. Dallman M.F., Strack A.M., Akana S.F., Bradbury M.J., Hanson E.S., Scribner K.A., and Smith M. Feast and famine: Critical role of glucocorticoids with insulin in daily energy flow. Front. Neuroendocrinol 14 (1993) 303-347
72. Dallman M.F., Akana S.F., Strack A.M., Hanson E.S., and Sebastian R.J. The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. Ann. NY Acad. Sci. 771 (1995) 730-742
73. Dash P.K., Hebert A.E., and Runyan J.D. A unified theory for systems and cellular memory consolidation. Brain Res. Rev. 45 (2004) 30-37
74. Dayanithi G., and Antoni F.A. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. Endocrinology 125 (1989) 308-313
75. De Caterina R., and Weksler B.B. Modulation of arachidonic acid metabolism in human endothelial cells by glucocorticoids. Thromb. Haemost. 55 (1986) 369-374
76. DeGeorge J.J., Noronha J.G., Bell J., Robinson P., and Rapoport S.I. Intravenous injection of [1-14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J. Neurosci. Res. 24 (1989) 413-423
77. Del Rey A., Besedovsky H., Sorkin E., and Dinarello C.A. Interleukin-1 and glucocorticoid hormones integrate an immunoregulatory feedback circuit. Ann. NY Acad. Sci. 496 (1987) 85-90
78. DeMar Jr. J.C., Lee H.J., Ma K., Chang L., Bell J.M., Rapoport S.I., and Bazinet R.P. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta 1761 (2006) 1050-1059
79. Dembinska-Kiec A., Korbut R., Zmuda A., Kostka-Trabka E., Simmet T., and Peskar B.A. Formation of lipoxygenase and cyclooxygenase metabolites of arachidonic acid by brain tissue. Biomed. Biochim. Acta 43 (1984) S222-S226
80. Dembinska-Kiec A., Simmet T., and Peskar B.A. Formation of leukotriene C4-like material by rat brain tissue. Eur. J. Pharmacol. 99 (1984) 57-62
81. Deutsch D.G., Glaser S.T., Howell J.M., Kunz J.S., Puffenbarger R.A., Hillard C.J., and Abumrad N. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J. Biol. Chem. 276 (2001) 6967-6973
82. Devane W.A., and Axelrod J. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc. Natl. Acad. Sci. USA 91 (1994) 6698-6701
83. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
84. Di S., Malcher-Lopes R., Halmos K.C., and Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism. J. Neurosci. 23 (2003) 4850-4857
85. Di S., Malcher-Lopes R., Marcheselli V.L., Bazan N.G., and Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 146 (2005) 4292-4301
86. Di S., Maxson M.M., Franco A., and Tasker J.G. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J. Neurosci. 29 2 (2009) 393-401
87. Diana M.A., and Marty A. Endocannabinoid-mediated short-term synaptic plasticity: Depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol. 142 (2004) 9-19
88. Di Marzo V. "Endocannabinoids" and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta 1392 (1998) 153-175
89. Di Marzo V., and Deutsch D.G. Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol. Dis. 5 (1998) 386-404
90. Di Marzo V., and Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidol. 18 (2007) 129-140
91. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., and Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 (1994) 686-691
92. Di Marzo V., De Petrocellis L., Sugiura T., and Waku K. Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. Biochem. Biophys. Res. Commun. 227 (1996) 281-288
93. Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Orlando P., Wagner J.A., and Kunos G. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264 (1999) 258-267
94. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., and Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
95. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A., and Bisogno T. Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 377-391
96. Dinh T.P., Freund T.F., and Piomelli D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem. Phys. Lipids 121 (2002) 149-158
97. Doherty N.S. Inhibition of arachidonic acid release as the mechanism by which glucocorticoids inhibit endotoxin-induced diarrhoea. Br. J. Pharmacol. 73 (1981) 549-554
98. Dore S., Otsuka T., Mito T., Sugo N., Hand T., Wu L., Hurn P.D., Traystman R.J., and Andreasson K. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann. Neurol. 54 (2003) 155-162
99. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12 (1998) 1063-1073
100. Edwards S.L., Anderson C.R., Southwell B.R., and McAllen R.M. Distinct preganglionic neurons innervate noradrenaline and adrenaline cells in the cat adrenal medulla. Neuroscience 70 (1996) 825-832
101. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-An integrative interface between two supersystems: The brain and the immune system. Pharmacol. Rev. 52 (2000) 595-638
102. Eljaschewitsch E., Witting A., Mawrin C., Lee T., Schmidt P.M., Wolf S., Hoertnagl H., Raine C.S., Schneider-Stock R., Nitsch R., and Ullrich O. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49 (2006) 67-79
103. Emmerling M.R., Moore C.J., Doyle P.D., Carroll R.T., and Davis R.E. Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 197 (1993) 292-297
104. Epps D.E., Schmid P.C., Natarajan V., and Schmid H.H. N-Acylethanolamine accumulation in infarcted myocardium. Biochem. Biophys. Res. Commun. 90 (1979) 628-633
105. Epps D.E., Natarajan V., Schmid P.C., and Schmid H.O. Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim. Biophys. Acta 618 (1980) 420-430
106. Fain J.N., Leffler C.W., Cowan Jr. G.S., Buffington C., Pouncey L., and Bahouth S.W. Stimulation of leptin release by arachidonic acid and prostaglandin E(2) in adipose tissue from obese humans. Metabolism 50 (2001) 921-928
107. Ferri C.C., and Ferguson A.V. Interleukin-1 beta depolarizes paraventricular nucleus parvocellular neurones. J. Neuroendocrinol 15 (2003) 126-133
108. Ferri C.C., and Ferguson A.V. Prostaglandin E2 mediates cellular effects of interleukin-1beta on parvocellular neurones in the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol 17 (2005) 498-508
109. Ferri C.C., Yuill E.A., and Ferguson A.V. Interleukin-1beta depolarizes magnocellular neurons in the paraventricular nucleus of the hypothalamus through prostaglandin-mediated activation of a non selective cationic conductance. Regul. Pept. 129 (2005) 63-71
110. Fletcher J.E., Jiang M.S., Gong Q.H., and Smith L.A. Snake venom cardiotoxins and bee venom melittin activate phospholipase C activity in primary cultures of skeletal muscle. Biochem. Cell Biol. 69 (1991) 274-281
111. Floman Y., and Zor U. Mechanism of steroid action in inflammation: Inhibition of prostaglandin synthesis and release. Prostaglandins 12 (1976) 403-413
112. Folkow B., and Von Euler U.S. Selective activation of noradrenaline and adrenaline producing cells in the cat's adrenal gland by hypothalamic stimulation. Circ. Res. 2 (1954) 191-195
113. Garcia D.E., Brown S., Hille B., and Mackie K. Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J. Neurosci. 18 (1998) 2834-2841
114. Gasperi V., Fezza F., Spagnuolo P., Pasquariello N., and Maccarrone M. Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. Neurotoxicology 26 (2005) 811-817
115. Gatley S.J., Gifford A.N., Volkow N.D., Lan R., and Makriyannis A. 123I-labeled AM251: A radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur. J. Pharmacol. 307 (1996) 331-338
116. Gonzalez S., Manzanares J., Berrendero F., Wenger T., Corchero J., Bisogno T., Romero J., Fuentes J.A., Di Marzo V., Ramos J.A., and Fernandez-Ruiz J. Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. Neuroendocrinology 70 (1999) 137-145
117. Goparaju S.K., Ueda N., Yamaguchi H., and Yamamoto S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett. 422 (1998) 69-73
118. Goppelt-Struebe M., Wolter D., and Resch K. Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase. Br. J. Pharmacol. 98 (1989) 1287-1295
119. Graber R., and Losa G.A. Changes in the activities of signal transduction and transport membrane enzymes in CEM lymphoblastoid cells by glucocorticoid-induced apoptosis. Anal. Cell Pathol. 8 (1995) 159-175
120. Griffin W.S., Sheng J.G., Roberts G.W., and Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54 (1995) 276-281
121. Gudermann T., Kalkbrenner F., and Schultz G. Diversity and selectivity of receptor-G protein interaction. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 429-459
122. Hampson A.J., Hill W.A., Zan-Phillips M., Makriyannis A., Leung E., Eglen R.M., and Bornheim L.M. Anandamide hydroxylation by brain lipoxygenase: Metabolite structures and potencies at the cannabinoid receptor. Biochim. Biophys. Acta 1259 (1995) 173-179
123. Hansen H.S., Lauritzen L., Strand A.M., Moesgaard B., and Frandsen A. Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. Biochim. Biophys. Acta 1258 (1995) 303-308
124. Hansen H.S., Moesgaard B., Hansen H.H., and Petersen G. N-Acylethanolamines and precursor phospholipids-Relation to cell injury. Chem. Phys. Lipids 108 (2000) 135-150
125. Harrison R.W., Balasubramanian K., Yeakley J., Fant M., Svec F., and Fairfield S. Heterogeneity of AtT-20 cell glucocorticoid binding sites: Evidence for a membrane receptor. Adv. Exp. Med. Biol. 117 (1979) 423-440
126. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron 45 (2005) 257-268
127. Hauwel M., Furon E., Canova C., Griffiths M., Neal J., and Gasque P. Innate (inherent) control of brain infection, brain inflammation and brain repair: The role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res. Brain Res. Rev. 48 (2005) 220-233
128. Hepler J.R., Kozasa T., Smrcka A.V., Simon M.I., Rhee S.G., Sternweis P.C., and Gilman A.G. Purification from Sf9 cells and characterization of recombinant Gq alpha and G11 alpha. Activation of purified phospholipase C isozymes by G alpha subunits. J. Biol. Chem. 268 (1993) 14367-14375
129. Hillard C.J., and Jarrahian A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids 108 (2000) 123-134
130. Hinz B., and Hirschelmann R. Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharm. Res. 17 (2000) 1273-1277
131. Ho W.S., and Randall M.D. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br. J. Pharmacol. 150 (2007) 641-651
132. Ho A.K., Chik C.L., and Klein D.C. Effects of protein kinase inhibitor (1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7) on protein kinase C activity and adrenergic stimulation of cAMP and cGMP in rat pinealocytes. Biochem. Pharmacol. 37 (1988) 1015-1020
133. Hoen P.A., Commandeur J.N., Vermeulen N.P., Van Berkel T.J., and Bijsterbosch M.K. Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes: Analysis with a novel reverse transcriptase-polymerase chain reaction assay section sign. Biochem. Pharmacol. 60 (2000) 1509-1518
134. Hogestatt E.D., Jonsson B.A., Ermund A., Andersson D.A., Bjork H., Alexander J.P., Cravatt B.F., Basbaum A.I., and Zygmunt P.M. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J. Biol. Chem. 280 (2005) 31405-31412
135. Hoozemans J.J., Veerhuis R., Janssen I., Rozemuller A.J., and Eikelenboom P. Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: Implications for Alzheimer's disease. Exp. Gerontol. 36 (2001) 559-570
136. Horrocks L.A. Sources for brain arachidonic acid uptake and turnover in glycerophospholipids. Ann. NY Acad. Sci. 559 (1989) 17-24
137. Hu S.S., Bradshaw H.B., Chen J.S., Tan B., and Walker J.M. Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. Br. J. Pharmacol. 153 (2008) 1538-1549
138. 2+ response in glial cells. Mol. Cells 19 (2005) 375-381
139. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S., and Ross M.E. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. USA 98 (2001) 1294-1299
140. Inoue W., Poole S., Bristow A.F., and Luheshi G.N. Leptin induces cyclooxygenase-2 via an interaction with interleukin-1beta in the rat brain. Eur. J. Neurosci. 24 (2006) 2233-2245
141. Iversen L., and Kragballe K. Arachidonic acid metabolism in skin health and disease. Prostaglandins Other Lipid Mediat. 63 (2000) 25-42
142. Jin T., Amzel M., Devreotes P.N., and Wu L. Selection of gbeta subunits with point mutations that fail to activate specific signaling pathways in vivo: Dissecting cellular responses mediated by a heterotrimeric G protein in Dictyostelium discoideum. Mol. Biol. Cell 9 (1998) 2949-2961
143. 2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. J. Biol. Chem. 282 (2007) 3614-3623
144. Jingami H., Matsukura S., Numa S., and Imura H. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 117 (1985) 1314-1320
145. Jo Y.H., Chen Y.J., Chua Jr. S.C., Talmage D.A., and Role L.W. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48 (2005) 1055-1066
146. John G.W., Doxey J.C., Walter D.S., and Reid J.L. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat. Br. J. Pharmacol. 100 (1990) 699-704
147. Jung K.M., Mangieri R., Stapleton C., Kim J., Fegley D., Wallace M., Mackie K., and Piomelli D. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 68 (2005) 1196-1202
148. Kagaya M., Lamb J., Robbins J., Page C.P., and Spina D. Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br. J. Pharmacol. 137 (2002) 39-48
149. Karanth S., Lyson K., Aguila M.C., and McCann S.M. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release. Neuroimmunomodulation 2 (1995) 166-173
150. Karbon E.W., Shenolikar S., and Enna S.J. Phorbol esters enhance neurotransmitter-stimulated cyclic AMP production in rat brain slices. J. Neurochem. 47 (1986) 1566-1575
151. Katsuura G., Gottschall P.E., Dahl R.R., and Arimura A. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: Possible involvement of prostaglandin. Endocrinology 122 (1988) 1773-1779
152. Katz A., Wu D., and Simon M.I. Subunits beta gamma of heterotrimeric G protein activate beta 2 isoform of phospholipase C. Nature 360 (1992) 686-689
153. Keller-Wood M.E., and Dallman M.F. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5 (1984) 1-24
154. Keller-Wood M., Leeman E., Shinsako J., and Dallman M.F. Steroid inhibition of canine ACTH: In vivo evidence for feedback at the corticotrope. Am. J. Physiol. 255 (1988) E241-E246
155. Kelley K.A., Ho L., Winger D., Freire-Moar J., Borelli C.B., Aisen P.S., and Pasinetti G.M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. 155 (1999) 995-1004
156. Kim J., and Alger B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci. 7 (2004) 697-698
157. Kim G.S., Hong J.S., Kim S.W., Koh J.M., An C.S., Choi J.Y., and Cheng S.L. Leptin induces apoptosis via ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells. J. Biol. Chem. 278 (2003) 21920-21929
158. Kirkham T.C., Williams C.M., Fezza F., and Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 136 (2002) 550-557
159. Knowlton B.J., and Fanselow M.S. The hippocampus, consolidation and on-line memory. Curr. Opin. Neurobiol. 8 (1998) 293-296
160. Kola B., et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3 (2008) e1797
161. Kondo S., Sugiura T., Kodaka T., Kudo N., Waku K., and Tokumura A. Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. Arch. Biochem. Biophys. 354 (1998) 303-310
162. Kozak K.R., and Marnett L.J. Oxidative metabolism of endocannabinoids. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 211-220
163. Kozak K.R., Rowlinson S.W., and Marnett L.J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J. Biol. Chem. 275 (2000) 33744-33749
164. Kozak K.R., Crews B.C., Morrow J.D., Wang L.H., Ma Y.H., Weinander R., Jakobsson P.J., and Marnett L.J. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem. 277 (2002) 44877-44885
165. Kozak K.R., Gupta R.A., Moody J.S., Ji C., Boeglin W.E., DuBois R.N., Brash A.R., and Marnett L.J. 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. J. Biol. Chem. 277 (2002) 23278-23286
166. Kruszka K.K., and Gross R.W. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor. J. Biol. Chem. 269 (1994) 14345-14348
167. Kunz T., and Oliw E.H. The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur. J. Neurosci. 13 (2001) 569-575
168. Kunz T., Marklund N., Hillered L., and Oliw E.H. Effects of the selective cyclooxygenase-2 inhibitor rofecoxib on cell death following traumatic brain injury in the rat. Restor. Neurol. Neurosci. 24 (2006) 55-63
169. Kunz A., Anrather J., Zhou P., Orio M., and Iadecola C. Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species. J. Cereb. Blood Flow Metab. 27 (2007) 545-551
170. Lapiz-Bluhm M.D., Soto-Pina A.E., Hensler J.G., and Morilak D.A. Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacology (Berl.) 202 1-3 (2009) 329-341
171. Lee S.B., Shin S.H., Hepler J.R., Gilman A.G., and Rhee S.G. Activation of phospholipase C-beta 2 mutants by G protein alpha q and beta gamma subunits. J. Biol. Chem. 268 (1993) 25952-25957
172. Lee S.Y., Park H.S., Lee S.J., and Choi M.U. Melittin exerts multiple effects on the release of free fatty acids from L1210 cells: Lack of selective activation of phospholipase A2 by melittin. Arch. Biochem. Biophys. 389 (2001) 57-67
173. Lee H., Villacreses N.E., Rapoport S.I., and Rosenberger T.A. In vivo imaging detects a transient increase in brain arachidonic acid metabolism: A potential marker of neuroinflammation. J. Neurochem. 91 4 (2004) 936-945
174. Leung D., Saghatelian A., Simon G.M., and Cravatt B.F. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45 (2006) 4720-4726
175. Lewis G.D., Campbell W.B., and Johnson A.R. Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology 119 (1986) 62-69
176. Lin L.L., Wartmann M., Lin A.Y., Knopf J.L., Seth A., and Davis R.J. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72 2 (1993) 269-278
177. Liu J., Wang L., Harvey-White J., Osei-Hyiaman D., Razdan R., Gong Q., Chan A.C., Zhou Z., Huang B.X., Kim H.Y., and Kunos G. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. USA 103 (2006) 13345-13350
178. Lovinger D.M. Presynaptic modulation by endocannabinoids. Handb. Exp. Pharmacol. (2008) 435-477
179. Lowenberg M., Tuynman J., Bilderbeek J., Gaber T., Buttgereit F., van Deventer S., Peppelenbosch M., and Hommes D. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 106 (2005) 1703-1710
180. Luheshi G.N., Gardner J.D., Rushforth D.A., Loudon A.S., and Rothwell N.J. Leptin actions on food intake and body temperature are mediated by IL-1. Proc. Natl. Acad. Sci. USA 96 (1999) 7047-7052
181. Maccarrone M., Bari M., Lorenzon T., Bisogno T., Di Marzo V., and Finazzi-Agro A. Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem. 275 (2000) 13484-13492
182. Maccarrone M., Di Rienzo M., Finazzi-Agro A., and Rossi A. Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3. J. Biol. Chem. 278 (2003) 13318-13324
183. Maccarrone M., Fride E., Bisogno T., Bari M., Cascio M.G., Battista N., Finazzi Agro A., Suris R., Mechoulam R., and Di Marzo V. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. Mol. Hum. Reprod. 11 (2005) 21-28
184. MacDonald J.F., Jackson M.F., and Beazely M.A. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors. Crit. Rev. Neurobiol. 18 (2006) 71-84
185. Madrigal J.L., Moro M.A., Lizasoain I., Lorenzo P., Fernandez A.P., Rodrigo J., Bosca L., and Leza J.C. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28 (2003) 1579-1588
186. Maier C., Runzler D., Schindelar J., Grabner G., Waldhausl W., Kohler G., and Luger A. G-protein-coupled glucocorticoid receptors on the pituitary cell membrane. J. Cell Sci. 118 (2005) 3353-3361
187. Malcher-Lopes R., Di S., Marcheselli V.S., Weng F.J., Stuart C.T., Bazan N.G., and Tasker J.G. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J. Neurosci. 26 (2006) 6643-6650
188. Malcher-Lopes R., Franco A., and Tasker J.G. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: A non-genomic anti-inflammatory switch. Eur. J. Pharmacol. 583 (2008) 322-339
189. Mancuso P., Canetti C., Gottschalk A., Tithof P.K., and Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L497-L502
190. Marchetti M.C., Di Marco B., Cifone G., Migliorati G., and Riccardi C. Dexamethasone-induced apoptosis of thymocytes: Role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 101 (2003) 585-593
191. Marsicano G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (2002) 530-534
192. Marx N., Duez H., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors and atherogenesis: Regulators of gene expression in vascular cells. Circ. Res. 94 (2004) 1168-1178
193. Matias I., et al. Prostaglandin ethanolamides (prostamides): In vitro pharmacology and metabolism. J. Pharmacol. Exp. Ther. 309 (2004) 745-757
194. Matsuwaki T., Kayasuga Y., Yamanouchi K., and Nishihara M. Maintenance of gonadotropin secretion by glucocorticoids under stress conditions through the inhibition of prostaglandin synthesis in the brain. Endocrinology 147 (2006) 1087-1093
195. McGiff J.C. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31 (1991) 339-369
196. McLay R.N., Kastin A.J., and Zadina J.E. Passage of interleukin-1-beta across the blood-brain barrier is reduced in aged mice: A possible mechanism for diminished fever in aging. Neuroimmunomodulation 8 (2000) 148-153
197. Mechoulam R., Fride E., and Di Marzo V. Endocannabinoids. Eur. J. Pharmacol. 359 (1998) 1-18
198. Meldrum E., Parker P.J., and Carozzi A. The PtdIns-PLC superfamily and signal transduction. Biochim. Biophys. Acta 1092 (1991) 49-71
199. Mitchell J.A., Belvisi M.G., Akarasereenont P., Robbins R.A., Kwon O.J., Croxtall J., Barnes P.J., and Vane J.R. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: Regulation by dexamethasone. Br. J. Pharmacol. 113 (1994) 1008-1014
200. Mollay C., Kreil G., and Berger H. Action of phospholipases on the cytoplasmic membrane of Escherichia coli. Stimulation by melittin. Biochim. Biophys. Acta 426 (1976) 317-324
201. Moody J.S., Kozak K.R., Ji C., and Marnett L.J. Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. Biochemistry 40 (2001) 861-866
202. Mrosovsky N., Molony L.A., Conn C.A., and Kluger M.J. Anorexic effects of interleukin 1 in the rat. Am. J. Physiol. 257 (1989) R1315-R1321
203. Murakami Y., Okada S., Nishihara M., and Yokotani K. Roles of brain prostaglandin E2 and thromboxane A2 in the activation of the central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 452 (2002) 289-294
204. Nakane S., Oka S., Arai S., Waku K., Ishima Y., Tokumura A., and Sugiura T. 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: Occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. Arch. Biochem. Biophys. 402 (2002) 51-58
205. Natarajan V., Schmid P.C., Reddy P.V., and Schmid H.H. Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J. Neurochem. 42 (1984) 1613-1619
206. Navarra P., Tsagarakis S., Faria M.S., Rees L.H., Besser G.M., and Grossman A.B. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128 (1991) 37-44
207. Newton R., Seybold J., Kuitert L.M., Bergmann M., and Barnes P.J. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J. Biol. Chem. 273 (1998) 32312-32321
208. Nirodi C.S., Crews B.C., Kozak K.R., Morrow J.D., and Marnett L.J. The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells. Proc. Natl. Acad. Sci. USA 101 (2004) 1840-1845
209. Nomura D.K., Hudak C.S., Ward A.M., Burston J.J., Issa R.S., Fisher K.J., Abood M.E., Wiley J.L., Lichtman A.H., and Casida J.E. Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. Bioorg. Med. Chem. Lett. 18 (2008) 5875-5878
210. O'Banion M.K., Miller J.C., Chang J.W., Kaplan M.D., and Coleman P.D. Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. 66 (1996) 2532-2540
211. Oka S., Yanagimoto S., Ikeda S., Gokoh M., Kishimoto S., Waku K., Ishima Y., and Sugiura T. Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. J. Biol. Chem. 280 (2005) 18488-18497
212. Okada S., Murakami Y., Nakamura K., and Yokotani K. Vasopressin V(1) receptor-mediated activation of central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 457 (2002) 29-35
213. Okada S., Shimizu T., and Yokotani K. Brain phospholipase C and diacylglycerol lipase are involved in corticotropin-releasing hormone-induced sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 475 (2003) 49-54
214. Okamoto Y., Morishita J., Tsuboi K., Tonai T., and Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279 (2004) 5298-5305
215. Ookuma K., Yoshimatsu H., Sakata T., Fujimoto K., and Fukagawa F. Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res. 490 (1989) 268-275
216. Panikashvili D., Shein N.A., Mechoulam R., Trembovler V., Kohen R., Alexandrovich A., and Shohami E. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol. Dis. 22 (2006) 257-264
217. Parsadaniantz S.M., Lebeau A., Duval P., Grimaldi B., Terlain B., and Kerdelhue B. Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat. J. Neuroendocrinol 12 (2000) 766-773
218. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., and Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145 (2004) 5431-5438
219. Paton G.S., Pertwee R.G., and Davies S.N. Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice. Neuropharmacology 37 (1998) 1123-1130
220. Patsos H.A., Hicks D.J., Dobson R.R., Greenhough A., Woodman N., Lane J.D., Williams A.C., and Paraskeva C. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: A possible role for cyclooxygenase 2. Gut 54 (2005) 1741-1750
221. Peinado-Onsurbe J., Soler C., Galan X., Poveda B., Soley M., Llobera M., and Ramirez I. Involvement of catecholamines in the effect of fasting on hepatic endothelial lipase activity in the rat. Endocrinology 129 (1991) 2599-2606
222. Pepicelli O., Fedele E., Berardi M., Raiteri M., Levi G., Greco A., Ajmone-Cat M.A., and Minghetti L. Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-D-aspartate receptors in rat hippocampus. J. Neurochem. 93 (2005) 1561-1567
223. Perez Roque M.E., Pasquare S.J., Castagnet P.I., and Giusto N.M. Can phosphorylation and dephosphorylation of rod outer segment membranes affect phosphatidate phosphohydrolase and diacylglycerol lipase activities?. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 119 (1998) 85-93
224. Pinteaux E., Inoue W., Schmidt L., Molina-Holgado F., Rothwell N.J., and Luheshi G.N. Leptin induces interleukin-1beta release from rat microglial cells through a caspase 1 independent mechanism. J. Neurochem. 102 (2007) 826-833
225. Piomelli D., Beltramo M., Glasnapp S., Lin S.Y., Goutopoulos A., Xie X.Q., and Makriyannis A. Structural determinants for recognition and translocation by the anandamide transporter. Proc. Natl. Acad. Sci. USA 96 (1999) 5802-5807
226. Pompeo A., Luini A., and Buccione R. Functional dissociation between glucocorticoid-induced decrease in arachidonic acid release and inhibition of adrenocorticotropic hormone secretion in AtT-20 corticotrophs. J. Steroid Biochem. Mol. Biol. 60 (1997) 51-57
227. Potestio F.A., and Olson D.M. Arachidonic acid release from cultured human amnion cells: The effect of dexamethasone. J. Clin. Endocrinol. Metab. 70 (1990) 647-654
228. Prescott S.M., and Majerus P.W. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J. Biol. Chem. 258 (1983) 764-769
229. Quan N., Whiteside M., and Herkenham M. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res. 802 (1998) 189-197
230. Quan N., He L., and Lai W. Endothelial activation is an intermediate step for peripheral lipopolysaccharide induced activation of paraventricular nucleus. Brain Res. Bull. 59 (2003) 447-452
231. Rall J.M., Mach S.A., and Dash P.K. Intrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats. Brain Res. 968 (2003) 273-276
232. Rao N.M. Differential susceptibility of phosphatidylcholine small unilamellar vesicles to phospholipases A2, C and D in the presence of membrane active peptides. Biochem. Biophys. Res. Commun. 182 (1992) 682-688
233. Recordati G. A thermodynamic model of the sympathetic and parasympathetic nervous systems. Auton. Neurosci. 103 (2003) 1-12
234. Rhee S.G., and Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272 (1997) 15045-15048
235. Riedel G., and Davies S.N. Cannabinoid function in learning, memory and plasticity. Handb. Exp. Pharmacol. (2005) 445-477
236. Ristimaki A., Narko K., and Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation. Biochem. J. 318 Pt. 1 (1996) 325-331
237. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., and Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: Review and critical analysis. Brain Res. Brain Res. Rev. 17 (1992) 187-214
238. Rockwell C.E., and Kaminski N.E. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. J. Pharmacol. Exp. Ther. 311 (2004) 683-690
239. Roozendaal B. Systems mediating acute glucocorticoid effects on memory consolidation and retrieval. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 1213-1223
240. Rosenberger T.A., Villacreses N.E., Hovda J.T., Bosetti F., Weerasinghe G., Wine R.N., Harry G.J., and Rapoport S.I. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88 5 (2004) 1168-1178
241. Rossi S., De Chiara V., Musella A., Kusayanagi H., Mataluni G., Bernardi G., Usiello A., and Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J. Neurosci. 28 (2008) 7284-7292
242. Rouzer C.A., and Marnett L.J. Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus. J. Biol. Chem. 280 (2005) 26690-26700
243. Rouzer C.A., and Marnett L.J. Non-redundant functions of cyclooxygenases: Oxygenation of endocannabinoids. J. Biol. Chem. 283 (2008) 8065-8069
244. Rowland N.E., Crews E.C., and Gentry R.M. Comparison of Fos induced in rat brain by GLP-1 and amylin. Regul. Pept. 71 (1997) 171-174
245. Rueda-Orozco P.E., Montes-Rodriguez C.J., Soria-Gomez E., Mendez-Diaz M., and Prospero-Garcia O. Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats. Neuropharmacology 55 (2008) 55-62
246. Saario S.M., Salo O.M., Nevalainen T., Poso A., Laitinen J.T., Jarvinen T., and Niemi R. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem. Biol. 12 (2005) 649-656
247. Sachot C., Poole S., and Luheshi G.N. Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats. J. Physiol. 561 (2004) 263-272
248. Sakata T., Yoshimatsu H., and Kurokawa M. Hypothalamic neuronal histamine: Implications of its homeostatic control of energy metabolism. Nutrition 13 (1997) 403-411
249. Sang N., Zhang J., and Chen C. PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. J. Physiol. 572 (2006) 735-745
250. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 (1987) 522-524
251. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21 (2000) 55-89
252. Sasaki T., Kitagawa K., Yamagata K., Takemiya T., Tanaka S., Omura-Matsuoka E., Sugiura S., Matsumoto M., and Hori M. Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice. J. Cereb. Blood Flow Metab. 24 (2004) 107-113
253. Satoh N., Ogawa Y., Katsuura G., Numata Y., Tsuji T., Hayase M., Ebihara K., Masuzaki H., Hosoda K., Yoshimasa Y., and Nakao K. Sympathetic activation of leptin via the ventromedial hypothalamus: Leptin-induced increase in catecholamine secretion. Diabetes 48 (1999) 1787-1793
254. Schelling J.R., Nkemere N., Konieczkowski M., Martin K.A., and Dubyak G.R. Angiotensin II activates the beta 1 isoform of phospholipase C in vascular smooth muscle cells. Am. J. Physiol. 272 (1997) C1558-C1566
255. Schleimer R.P., Davidson D.A., Lichtenstein L.M., and Adkinson Jr. N.F. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. J. Immunol. 136 (1986) 3006-3011
256. Schmid H.H. Pathways and mechanisms of N-acylethanolamine biosynthesis: Can anandamide be generated selectively?. Chem. Phys. Lipids 108 (2000) 71-87
257. Schmid H.H., and Berdyshev E.V. Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: Metabolism and function. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 363-376
258. Schmid H.H., Schmid P.C., and Natarajan V. N-acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29 (1990) 1-43
259. Schmid P.C., Krebsbach R.J., Perry S.R., Dettmer T.M., Maasson J.L., and Schmid H.H. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 375 (1995) 117-120
260. Schmidt P., Holsboer F., and Spengler D. Beta(2)-adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein beta gamma-subunits and the phosphoinositide 3-kinase pathway. Mol. Endocrinol. 15 (2001) 553-564
261. Schnabel P., Camps M., Carozzi A., Parker P.J., and Gierschik P. Mutational analysis of phospholipase C-beta 2. Identification of regions required for membrane association and stimulation by guanine-nucleotide-binding protein beta gamma subunits. Eur. J. Biochem. 217 (1993) 1109-1115
262. Schwarz P.M., Gierten B., Boissel J.P., and Forstermann U. Expressional down-regulation of neuronal-type nitric oxide synthase I by glucocorticoids in N1E-115 neuroblastoma cells. Mol. Pharmacol. 54 (1998) 258-263
263. Seeds M.C., and Bass D.A. Regulation and metabolism of arachidonic acid. Clin. Rev. Allergy Immunol. 17 (1999) 5-26
264. Selye H. Stress and the general adaptation syndrome. Br. Med. J. 1 (1950) 1383-1392
265. Shaw K.N., Commins S., and O'Mara S.M. Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad-spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain-derived neurotrophic factor. Eur. J. Neurosci. 17 (2003) 2438-2446
266. Shiflett M.W., Rankin A.Z., Tomaszycki M.L., and DeVoogd T.J. Cannabinoid inhibition improves memory in food-storing birds, but with a cost. Proc. Biol. Sci. 271 (2004) 2043-2048
267. Shimizu T., and Yokotani K. Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats. Eur. J. Pharmacol. 582 (2008) 62-69
268. Shimizu T., Okada S., Yamaguchi-Shima N., and Yokotani K. Brain phospholipase C-diacylglycerol lipase pathway is involved in vasopressin-induced release of noradrenaline and adrenaline from adrenal medulla in rats. Eur. J. Pharmacol. 499 (2004) 99-105
269. Shimizu T., Okada S., Yamaguchi N., Arai J., Wakiguchi H., and Yokotani K. Brain phospholipase C/diacylglycerol lipase are involved in bombesin BB2 receptor-mediated activation of sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 514 (2005) 151-158
270. Shimizu T., Yamaguchi N., Okada S., Lu L., Sasaki T., and Yokotani K. Roles of brain phosphatidylinositol-specific phospholipase C and diacylglycerol lipase in centrally administered histamine-induced adrenomedullary outflow in rats. Eur. J. Pharmacol. 571 (2007) 138-144
271. Simon G.M., and Cravatt B.F. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J. Biol. Chem. 281 (2006) 26465-26472
272. Slanina K.A., Roberto M., and Schweitzer P. Endocannabinoids restrict hippocampal long-term potentiation via CB1. Neuropharmacology 49 (2005) 660-668
273. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: Structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
274. Smrcka A.V., Hepler J.R., Brown K.O., and Sternweis P.C. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science 251 (1991) 804-807
275. Snider N.T., Kornilov A.M., Kent U.M., and Hollenberg P.F. Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. J. Pharmacol. Exp. Ther. 321 (2007) 590-597
276. Snider N.T., Sikora M.J., Sridar C., Feuerstein T.J., Rae J.M., and Hollenberg P.F. The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. J. Pharmacol. Exp. Ther. 327 (2008) 538-545
277. Song L., Che W., Min-Wei W., Murakami Y., and Matsumoto K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol. Biochem. Behav. 83 (2006) 186-193
278. Stark K., Dostalek M., and Guengerich F.P. Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. FEBS J. 275 (2008) 3706-3717
279. Steiner M.R., Bomalaski J.S., and Clark M.A. Responses of purified phospholipases A2 to phospholipase A2 activating protein (PLAP) and melittin. Biochim. Biophys. Acta 1166 (1993) 124-130
280. Stella N., Tence M., Glowinski J., and Premont J. Glutamate-evoked release of arachidonic acid from mouse brain astrocytes. J. Neurosci. 14 (1994) 568-575
281. Stella N., Schweitzer P., and Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (1997) 773-778
282. Sugiura T., Kondo S., Sukagawa A., Tonegawa T., Nakane S., Yamashita A., Ishima Y., and Waku K. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. Eur. J. Biochem. 240 (1996) 53-62
283. Sugiura T., Kobayashi Y., Oka S., and Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 173-192
284. Sugiura T., Oka S., Gokoh M., Kishimoto S., and Waku K. New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. J. Pharmacol. Sci. 96 (2004) 367-375
285. Sun Y.X., Tsuboi K., Okamoto Y., Tonai T., Murakami M., Kudo I., and Ueda N. Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem. J. 380 (2004) 749-756
286. Suzuki A., Mitsuda S., Higashio K., and Kumasaka T. Participation of phospholipase A2 in induction of tissue plasminogen activator (t-PA) production by human fibroblast, IMR-90 cells, stimulated by proteose peptone. Thromb. Res. 64 (1991) 191-202
287. Swanson L.W., and Sawchenko P.E. Paraventricular nucleus: A site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31 (1980) 410-417
288. Takahashi R.N., Pamplona F.A., and Fernandes M.S. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci. Lett. 380 (2005) 270-275
289. Tanaka H., Watanabe K., Tamaru N., and Yoshida M. Arachidonic acid metabolites and glucocorticoid regulatory mechanism in cultured porcine tracheal smooth muscle cells. Lung 173 (1995) 347-361
290. Tassoni D., Kaur G., Weisinger R.S., and Sinclair A.J. The role of eicosanoids in the brain. Asia Pac. J. Clin. Nutr. 17 Suppl. 1 (2008) 220-228
291. Teather L.A., Packard M.G., and Bazan N.G. Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation. Learn. Mem. 9 (2002) 41-47
292. Tempel D.L., Kim T., and Leibowitz S.F. The paraventricular nucleus is uniquely responsive to the feeding stimulatory effects of steroid hormones. Brain Res. 614 (1993) 197-204
293. Terranova J.P., Michaud J.C., Le Fur G., and Soubrie P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: Reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch. Pharmacol. 352 (1995) 576-579
294. Tong D.C., Buck S.M., Roberts B.R., Klein J.D., and Tumlin J.A. Calcineurin phosphatase activity: Activation by glucocorticoids and role of intracellular calcium. Transplantation 77 (2004) 259-267
295. Tsutsumi T., Kobayashi T., Ueda H., Yamauchi E., Watanabe S., and Okuyama H. Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes. Neurochem. Res. 19 (1994) 399-406
296. Tsutsumi T., Kobayashi T., Miyashita M., Watanabe S., Homma Y., and Okuyama H. A lysophosphoinositide-specific phospholipase C distinct from other phospholipase C families in rat brain. Arch. Biochem. Biophys. 317 (1995) 331-336
297. Turton M.D., et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 (1996) 69-72
298. Ueda H., Kobayashi T., Kishimoto M., Tsutsumi T., and Okuyama H. A possible pathway of phosphoinositide metabolism through EDTA-insensitive phospholipase A1 followed by lysophosphoinositide-specific phospholipase C in rat brain. J. Neurochem. 61 (1993) 1874-1881
299. Uehara A., Sekiya C., Takasugi Y., Namiki M., and Arimura A. Anorexia induced by interleukin 1: Involvement of corticotropin-releasing factor. Am. J. Physiol. 257 (1989) R613-R617
300. Ullrich O., Schneider-Stock R., and Zipp F. Cell-cell communication by endocannabinoids during immune surveillance of the central nervous system. Results Probl. Cell Differ. 43 (2006) 281-305
301. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
302. Varvel S.A., Anum E.A., and Lichtman A.H. Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology (Berl.) 179 (2005) 863-872
303. Varvel S.A., Wise L.E., Niyuhire F., Cravatt B.F., and Lichtman A.H. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology 32 (2007) 1032-1041
304. Vellani V., Petrosino S., De Petrocellis L., Valenti M., Prandini M., Magherini P.C., McNaughton P.A., and Di Marzo V. Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. Neuropharmacology 55 (2008) 1274-1279
305. Verty A.N., McGregor I.S., and Mallet P.E. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology 49 (2005) 1101-1109
306. Vishwanath B.S., Frey F.J., Bradbury M.J., Dallman M.F., and Frey B.M. Glucocorticoid deficiency increases phospholipase A2 activity in rats. J. Clin. Invest. 92 (1993) 1974-1980
307. Vollmer R.R., Balcita J.J., Sved A.F., and Edwards D.J. Adrenal epinephrine and norepinephrine release to hypoglycemia measured by microdialysis in conscious rats. Am. J. Physiol. 273 (1997) R1758-R1763
308. Wahn H., Wolf J., Kram F., Frantz S., and Wagner J.A. The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H2491-H2496
309. Wenger T., Fernandez-Ruiz J.J., and Ramos J.A. Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland. J. Neuroendocrinol 11 (1999) 873-878
310. Wettschureck N., van der Stelt M., Tsubokawa H., Krestel H., Moers A., Petrosino S., Schutz G., Di Marzo V., and Offermanns S. Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation. Mol. Cell Biol. 26 (2006) 5888-5894
311. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592
312. Wise L.E., Iredale P.A., Stokes R.J., and Lichtman A.H. Combination of rimonabant and donepezil prolongs spatial memory duration. Neuropsychopharmacology 32 (2007) 1805-1812
313. Wolff M.C., and Leander J.D. SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. Eur. J. Pharmacol. 477 (2003) 213-217
314. Woodward D.F., Krauss A.H., Wang J.W., Protzman C.E., Nieves A.L., Liang Y., Donde Y., Burk R.M., Landsverk K., and Struble C. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris. Br. J. Pharmacol. 150 (2007) 342-352
315. Woodward D.F., Carling R.W., Cornell C.L., Fliri H.G., Martos J.L., Pettit S.N., Liang Y., and Wang J.W. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol. Ther. 120 (2008) 71-80
316. Wright T.M., Rangan L.A., Shin H.S., and Raben D.M. Kinetic analysis of 1,2-diacylglycerol mass levels in cultured fibroblasts. Comparison of stimulation by alpha-thrombin and epidermal growth factor. J. Biol. Chem. 263 (1988) 9374-9380
317. Wurtman R.J. Stress and the adrenocortical control of epinephrine synthesis. Metabolism 51 (2002) 11-14
318. Yamaguchi-Shima N., Okada S., Shimizu T., Usui D., Nakamura K., Lu L., and Yokotani K. Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine-vasopressin in rats. Eur. J. Pharmacol. 564 (2007) 94-102
319. Yamamoto S. Mammalian lipoxygenases: Molecular structures and functions. Biochim. Biophys. Acta 1128 (1992) 117-131
320. Yang H., and Chen C. Cyclooxygenase-2 in synaptic signaling. Curr. Pharm. Des. 14 (2008) 1443-1451
321. Yang H., Wang L., and Ju G. Evidence for hypothalamic paraventricular nucleus as an integrative center of neuroimmunomodulation. Neuroimmunomodulation 4 (1997) 120-127
322. Yang Y.L., Chao P.K., and Lu K.T. Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 31 (2006) 912-924
323. Yang H., Zhang J., Andreasson K., and Chen C. COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity. Mol. Cell Neurosci. 37 (2008) 682-695
324. Yokotani K., Okuma Y., and Osumi Y. Recombinant interleukin-1 beta inhibits gastric acid secretion by activation of central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 279 (1995) 233-239
325. Yokotani K., Wang M., Murakami Y., Okada S., and Hirata M. Brain phospholipase A(2)-arachidonic acid cascade is involved in the activation of central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 398 (2000) 341-347
326. Yokotani K., Murakami Y., Okada S., and Hirata M. Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 419 (2001) 183-189
327. Yousufzai S.Y., and Abdel-latif A.A. Endothelin-1 stimulates the release of arachidonic acid and prostaglandins in cultured human ciliary muscle cells: Activation of phospholipase A2. Exp. Eye Res. 65 (1997) 73-81
328. Yu M., Ives D., and Ramesha C.S. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J. Biol. Chem. 272 (1997) 21181-21186
329. Zeitler P., Wu Y.Q., and Handwerger S. Melittin stimulates phosphoinositide hydrolysis and placental lactogen release: Arachidonic acid as a link between phospholipase A2 and phospholipase C signal-transduction pathways. Life Sci. 48 (1991) 2089-2095
330. Zhang J., and Chen C. Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation. J. Biol. Chem. 283 (2008) 22601-22611